Chin-Chung Shu, MD
National Taiwan University Hospital
9
9
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Raymond Vanholder, MD, PhD
University Hospital, Ghent
Shared therapeutic areas:
Jae-Joon Yim, MD
Seoul National University Hospital
Shared therapeutic areas:
E. Steve Woodle, MD
University of Cincinnati
Shared therapeutic areas:
Paul Perez, Dr
University Hospital, Bordeaux
Shared therapeutic areas:
Sung-Han Kim, MD
Asan Medical Center
Shared therapeutic areas:
Peter S. Heeger, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Won Ho Kim, M.D.
Samsung Medical Center
Shared therapeutic areas:
Jan-Stephan F Sanders, MD PhD
University Medical Center Groningen
Shared therapeutic areas:
Thomas R Porter, MD
University of Nebraska
Shared therapeutic areas:
Sarah Schrauben, MD, MSCE
University of Pennsylvania
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
Serum Inflammatory Marker in Patients With Diagnosis of Nontuberculous Mycobacterial Pulmonary Infection
Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis
Establishing a Diagnostic Test for Non-tuberculous Mycobacteria Lung Infection Using Non-tuberculous Mycobacteria Antigen Stimulation Test: From Immune Base, Standardized Setup to Validation
The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis
Surveillance and Follow-up for Latent Tuberculosis Infection and Observation of the Effect of Prophylactic Latent Tuberculosis Treatment in Patients With Severe Chronic Kidney Disease or Receiving Long-term Dialysis
Evaluating the Diagnostic Validity of Inflammation-associated Markers for Tuberculous Pleurisy
The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease
Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung Disease
Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
All 9 trials loaded